D
Daniel K. Benjamin
Researcher at Duke University
Publications - 365
Citations - 22525
Daniel K. Benjamin is an academic researcher from Duke University. The author has contributed to research in topics: Population & Intensive care. The author has an hindex of 69, co-authored 354 publications receiving 20168 citations. Previous affiliations of Daniel K. Benjamin include Clemson University & Food and Drug Administration.
Papers
More filters
Journal ArticleDOI
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Peter G. Pappas,Carol A. Kauffman,David R. Andes,Daniel K. Benjamin,Thierry Calandra,John E. Edwards,Scott G. Filler,John F. Fisher,Bart Jan Kullberg,Luis Ostrosky-Zeichner,Annette C. Reboli,John H. Rex,Thomas J. Walsh,Jack D. Sobel +13 more
TL;DR: These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections.
Journal ArticleDOI
Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants.
C. Michael Cotten,Sarah A. Taylor,Barbara J. Stoll,Ronald N. Goldberg,Nellie I. Hansen,Pablo J. Sánchez,Namasivayam Ambalavanan,Daniel K. Benjamin +7 more
TL;DR: Prolonged initial empirical antibiotic therapy may be associated with increased risk of necrotizing enterocolitis or death and should be used with caution.
Journal ArticleDOI
10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
Helen W. Boucher,George H. Talbot,Daniel K. Benjamin,Daniel K. Benjamin,John S. Bradley,John S. Bradley,Robert Guidos,Ronald N. Jones,Barbara E. Murray,Robert A. Bonomo,David N. Gilbert,David N. Gilbert +11 more
TL;DR: This survey demonstrates some progress in development of new antibacterial drugs that target infections caused by resistant GNB, but progress remains alarmingly elusive.
Journal ArticleDOI
Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months
Daniel K. Benjamin,Barbara J. Stoll,Avory A. Fanaroff,Scott A. McDonald,William Oh,Rosemary D. Higgins,Shahnaz Duara,Kenneth Poole,Abbot R. Laptook,Ronald N. Goldberg +9 more
TL;DR: In multivariate analysis of risk factors on day of life 3, birth weight, cephalosporins, gender, and lack of enteral feeding were associated with development of candidiasis, and delayed catheter removal was associated with increased death and NDI rates.
Journal ArticleDOI
Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units.
Christoph P. Hornik,P. Fort,Reese H. Clark,Kevin M. Watt,Kevin M. Watt,Daniel K. Benjamin,Daniel K. Benjamin,P B Smith,P B Smith,Paolo Manzoni,Evelyne Jacqz-Aigrain,Florentia Kaguelidou,Michael Cohen-Wolkowiez,Michael Cohen-Wolkowiez +13 more
TL;DR: The purpose of this study was to determine the risk factors for sepsis, the causative organisms, and mortality following infection in a large and diverse sample of NICUs, and to conclude that overall mortality in VLBW infants with early- and late-onset sepsi is higher than in infants with negative cultures.